About Hannah Brown, MD
Dr. Brown is an Instructor in Psychiatry at Harvard Medical School and faculty psychiatrist at Massachusetts General Hospital (MGH). She earned her MD from Harvard Medical School, completed residency training in adult psychiatry in the MGH/McLean program and completed a fellowship in schizophrenia at MGH. Her current clinical and research interests are in the field of schizophrenia. Her clinical work is centered in the First Episode and Early Psychosis Program and in the Acute Psychiatry Service.
Treats:
- Adult
Locations
Mass General Psychiatry: Adult Outpatient Psychiatry Services
55 Fruit St.
Wang Ambulatory Care Center
Boston, MA 02114
Phone: 617-724-7792
Medical Education
- MD, Harvard Medical School
- Residency, Massachusetts General Hospital*****
American Board Certifications
- Psychiatry, American Board of Psychiatry and Neurology
Accepted Insurance Plans
- Aetna Health Inc.
- Beech Street
- Blue Cross Blue Shield - Blue Care 65
- Blue Cross Blue Shield - Indemnity
- Blue Cross Blue Shield - Managed Care
- Blue Cross Blue Shield - Partners Plus
- BMC HealthNet Mass Health MCO/ACO
- Centene/Celticare
- Cigna Behavioral Health
- Commonwealth Care Alliance
- Great-West Healthcare (formally One Health Plan)
- Health Care Value Management (HCVM)
- Humana/Choice Care PPO
- MassHealth
- Medicare
- Medicare - ACD
- Medicare ACO - ACD
- Medicare ACO - PBO
- OSW - Connecticut
- OSW - Maine
- OSW - New Hampshire
- OSW - Rhode Island
- OSW - Vermont
- Private Health Care Systems (PHCS)
- Senior Whole Health
- TriCare
- Tufts Health Plan
- Unicare
- United Behavioral Health
- United Behavioral Health - MGH
- Well Sense Pediatrics
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Research
Dr. Brown's research focuses on using human induced pluripotent stem cells derived from patients with schizophrenia as a tool to investigate cellular biology and drug response. In collaboration with both Dr. Roffman and Dr. Roy Perlis, director of the Center for Experimental Drugs and Diagnostics at MGH, she is examining characteristics of stem cells derived from a cohort of schizophrenia patients who carry specific genetic variants in the folate metabolic pathway. She is also examining drug treatment response in stem cells from patients with treatment-resistant schizophrenia.
She is a recipient of a 2013 NARSAD Young Investigator Grant and the APA Early Academic Career Award on Schizophrenia Research, as well as a 2014 Dupont-Warren Fellowship awarded through Harvard Department of Psychiatry.